<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="146386">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02019186</url>
  </required_header>
  <id_info>
    <org_study_id>CCRI-VITCE</org_study_id>
    <nct_id>NCT02019186</nct_id>
  </id_info>
  <brief_title>Effects of Vitamin C and E on Endothelial Function in Adolescent Diabetes</brief_title>
  <official_title>Effects of Vitamin C and E on Endothelial Function in Adolescent Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nationwide Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nationwide Children's Hospital</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The endothelium is the lining of the blood vessels that helps prevent damage to the vessels.
      The endothelium does not function as well as it should in adolescents with type 1 diabetes.
      This causes future diabetes complications.  Adolescents with diabetes also have
      abnormalities of the cells that repair the endothelium.  These abnormalities may be due to
      damage caused by intermittent hyperglycemia. This studied is designed to study whether low
      dose, combined Vitamin C and E supplementation improves endothelial function and repair in
      adolescents with type 1 diabetes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>endothelial function</measure>
    <time_frame>6 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Endothelial function will be measured before and after 6 weeks of therapy with Vitamin C and  E</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Endothelial progenitor cells</measure>
    <time_frame>6 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Endothelial progenitor cells will be measured before and after 6 weeks of Vitamin C and E therapy</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Vitamin C and E</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6 weeks of daily treatment with Vitamin C and E</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin C</intervention_name>
    <description>&lt;30 kg	                                                     250 mg 30-60 kg	                                                     500 mg &gt;60 kg	                                                     750 mg</description>
    <arm_group_label>Vitamin C and E</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin E</intervention_name>
    <description>&lt;30 kg 100 IU, 30-60 kg 200 IU, &gt;60 kg 300 IU</description>
    <arm_group_label>Vitamin C and E</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Children and adolescent with T1D between 8 and 15 years of age will be studied.

          2. Started on insulin therapy immediately after diagnosis.

          3. Fasting c-peptide levels must be less than 0.4 ng/ml.

          4. Hgb A1c levels greater than 8.3%.

          5. All subjects must be in good health other than having diabetes. Subjects with
             hypothyroidism will be allowed assuming they are on stable thyroxine replacement and
             have normal thyroid function tests.

          6. Females on oral contraceptives will also be eligible to participate.

        Exclusion Criteria:

          1. History oral hypoglycemic agent use.

          2. BMI&gt;95th percentile

          3. Hypertension

          4. Elevated creatinine levels

          5. Microalbuminuria.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Research Institute at Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert P Hoffman, MD</last_name>
      <phone>614-722-4425</phone>
      <email>robert.hoffman@nationwidechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Robert P Hoffman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rachel Cazeau, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Hoffman RP, Dye AS, Bauer JA. Ascorbic acid blocks hyperglycemic impairment of endothelial function in adolescents with type 1 diabetes. Pediatr Diabetes. 2012 Dec;13(8):607-10. doi: 10.1111/j.1399-5448.2012.00882.x. Epub 2012 Aug 28.</citation>
    <PMID>22925199</PMID>
  </reference>
  <reference>
    <citation>Dye AS, Huang H, Bauer JA, Hoffman RP. Hyperglycemia increases muscle blood flow and alters endothelial function in adolescents with type 1 diabetes. Exp Diabetes Res. 2012;2012:170380. doi: 10.1155/2012/170380. Epub 2012 Jun 3.</citation>
    <PMID>22701470</PMID>
  </reference>
  <reference>
    <citation>Varvarovská J, Racek J, Stozický F, Soucek J, Trefil L, Pomahacová R. Parameters of oxidative stress in children with Type 1 diabetes mellitus and their relatives. J Diabetes Complications. 2003 Jan-Feb;17(1):7-10.</citation>
    <PMID>12505749</PMID>
  </reference>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 23, 2013</lastchanged_date>
  <firstreceived_date>December 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nationwide Children's Hospital</investigator_affiliation>
    <investigator_full_name>Robert Hoffman</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>type 1 diabetes</keyword>
  <keyword>endothelial function</keyword>
  <keyword>adolescents</keyword>
  <keyword>vitamin C</keyword>
  <keyword>vitamin E</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Alpha-Tocopherol</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
